CSIMarket
 
Xortx Therapeutics Inc   (XRTX)
Other Ticker:  
 
 
Price: $5.1700 $-0.24 -4.436%
Day's High: $5.81 Week Perf: 16.18 %
Day's Low: $ 5.07 30 Day Perf: 135 %
Volume (M): 71 52 Wk High: $ 7.00
Volume (M$): $ 368 52 Wk Avg: $1.33
Open: $5.54 52 Wk Low: $0.25



 Market Capitalization (Millions $) 50
 Shares Outstanding (Millions) 10
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Xortx Therapeutics Inc
Xortx Therapeutics Inc is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for the treatment of kidney diseases. The company is dedicated to improving the quality of life for patients with kidney-related conditions by developing novel drugs that target the underlying causes of these diseases. Xortx Therapeutics is known for its expertise in the field of renal biology and is committed to advancing the standard of care for kidney disease patients through its research and development efforts.


   Company Address: Suite 2400 - 745 Thurlow Street British Columbia 0
   Company Phone Number: 455-7727   Stock Exchange / Ticker: NASDAQ XRTX
   XRTX is expected to report next financial results on April 27, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Financing Agreement

XORTX Secures $2.7 Million in Funding Through Unique Fundraising Strategy

Published Mon, Mar 4 2024 12:00 PM UTC

XORTX Finalizes $2.7 Million Fundraising Strategy Amidst Growing Demand
In a move aimed at capitalizing on the increasing demand for its innovative offerings, XORTX Therapeutics Inc. has recently concluded a successful fundraising round totaling $2.7 million through a combination of a prospectus supplement and a concurrent private placement. The company, which specialize...

Financing Agreement

XORTX Faces Mounting Challenges as Quick Ratio Ranking Continues to Decline

Published Fri, Feb 2 2024 1:46 AM UTC



In a recent press release, Xortx Therapeutics Inc, a prominent player in the industry, reported its Quick Ratio ranking for the fourth quarter of 2021. While the company has managed to maintain a fairly stable position, it falls behind a significant number of its industry peers. This article aims to delve into the facts provided in the press release, outlining thei...

Shares

XORTX Therapeutics Revolutionizes Trading Potential with Consolidation to Advance Progressive Kidney Disease Therapies

Published Fri, Nov 10 2023 12:00 PM UTC



CALGARY, Alberta, Nov. 10, 2023 - XORTX Therapeutics Inc. (XORTX) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a leading clinical pharmaceutical company focusing on groundbreaking therapies for progressive kidney disease, has recently announced the Consolidation of its common shares. The company's decision to undertake this consolidation aims to streamline its equ...

Shares

XORTX Therapeutics Inc. Consolidates Shares: Paving the Way for Growth and Advances in Kidney Disease Treatment

Published Wed, Nov 8 2023 10:00 PM UTC

XORTX Announces Share Consolidation: A Strategic Move Towards Progress
By
CALGARY, Alberta, Nov. 08, 2023 - XORTX Therapeutics Inc. (XORTX or the Company) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company with a focus on innovative therapies for progressive kidney disease, has recently made a significant announcement. The Com...






 

Xortx Therapeutics Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com